11 results
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
Doses of Drugs for Treatment ... Multidrug-Resistant Tuberculosis ... #MDRTB #management ... #Treatment #antimicrobials ... #pharmacology #
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
drugs for use in a treatment ... multidrug-resistant tuberculosis ... MultiDrugResistant #Tuberculosis ... #MDRTB #management ... #pharmacology #
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... 1: Choose one later-generation ... #MDRTB #management ... #regimens #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... (Anorexia) • Night ... Treatment: Active ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Diagnosis and Management ... Lung Abscess Pathophysiology ... degrees • Chills, night ... weight loss • Late ... CXR upright or lat
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... (Anorexia) • Night ... Treatment: Active ... TB #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... Mycobacterium #Tuberculosis ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
1 dose (BII) Late-Latent ... 28 days (BIII) Late-Stage ... IDSA #Prevention #Treatment ... #infections #HIVAIDS ... #pharmacology
Compartment Syndrome Pearls
A vicious cycle of increased pressure within a facial compartment leading to compression of
Pathophysiology: ... Paraesthesia (pinprick, light ... , the rest are late ... onset of ischemia Treatment ... Syndrome #diagnosis #management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
effective for treatment ... Therapy—For Immediate Sight ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology